The role of tumor oxygenation in vascular and clinical response to angiogenesis inhibition

Advances in Experimental Medicine and Biology

Volumn 510, Issue , 2003, Pages 1-5

  Gee, Michael S ^b   Lee, William M F ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 NITRO 1H IMIDAZOL 1 YL) N (2,2,3,3,3 PENTAFLUOROPROPYL)ACETAMIDE; ANGIOGENESIS INHIBITOR; CC 9088; HYPOXIA INDUCIBLE FACTOR 1; NITROIMIDAZOLE DERIVATIVE; RECOMBINANT INTERLEUKIN 12; SELCID 88; THALIDOMIDE DERIVATIVE; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; BINDING KINETICS; CELL HYPOXIA; CONFERENCE PAPER; CONTROLLED STUDY; CYTOTOXICITY; DISEASE ACTIVITY; DISEASE MARKER; FEMALE; HISTOLOGY; HYPOXIA; INHIBITION KINETICS; MELANOMA; MELANOMA CELL; MICROVASCULATURE; MOUSE; NONHUMAN; PATIENT MONITORING; PRIORITY JOURNAL; PROTEIN DETERMINATION; REDUCTION; TISSUE OXYGENATION; TUMOR CELL; TUMOR VASCULARIZATION; VALIDATION PROCESS; VASCULAR DISEASE;

ANIMALIA;

EID: 0037225847     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4615-0205-0_1     Document Type: Conference Paper

References (8)

1. J. Folkman, Tumor angiogenesis: therapeutic implications, N. Eng. J. Med. 285, 1182-1186, (1971).
2. N. J. Nelson, Inhibitors of angiogenesis enter phase III testing, J. Natl. Cancer Inst. 90, 960-963 (1998).
3. M. S. Gee, et al., Hypoxia-mediated apoptosis from angiogenesis inhibition underlies tumor control by recombinant interleukin 12, Cancer Res. 59, 4882-4889, (1999).
4. M. S. Gee, H. M. Saunders, J. C. Lee, J. F. Sanzo, W. T. Jenkins, S. M. Evans, G. Trinchieri, W. M. F. Lee, Doppler ultrasound imaging detects changes in tumor perfusion during antivascular therapy associated with vascular anatomic alterations, Cancer Res. 61, 2974-2982, (2001).
5. C. J. Koch, S. M. Evans, and E. M. Lord, Oxygen dependence of cellular uptake of EF5: analysis of drug adducts by fluorescent antibodies vs bound radioactivity, Br. J. Cancer 72, 869-874, (1995).
6. S. M. Evans, et al, Detection of hypoxia in human squamous cell carcinoma by EF5 binding, Cancer Res. 60, 2018-2024, (2000).
7. G. L. Semenza, HIF-1: mediator of physiological and pathophysiological responses to hypoxia, J. Appl. Physiol. 88, 1474-1480, (2000).
8. N. J. Beasley, C. C. Wykoff, P. H. Watson, R. Leek, H. Turley, K. Gatter, J. Pastorek, G. J. Cox, P. Ratcliffe, and A. L. Harris, Carbonic anhydrase IX, an endogenous hypoxia marker, expression in head and neck squamous cell carcinoma and its relationship to hypoxia, necrosis and microvessel density, Cancer Res. 61, 5262-5267, (2001).